In partnership with

Alumni Ventures

Today in 30 seconds

  • AGX math: About $44.10 → $374.40 over five years, roughly +749%. The business behind it just posted record quarterly revenue of $384 million, up 61.5% year over year.

  • Honest catch: The stock hit a $805.75 52-week high in June, then was cut roughly in half. A strong business does not stop a stock from falling hard.

  • Bigger lesson: A five-year line can stay deeply green while the recent high is far away. Weigh the long run, not the last spike.

  • Action: If you follow a fast mover like AGX, set your monthly amount and position size before the next big swing, not in the middle of it.

  • Premium sponsor: Alumni Ventures — early access to startup deals (no cost to see, no obligation). See current deals

What do you do with a stock that rose more than 700% in five years, then lost roughly half its value in a few months? 👀

Today we look at Argan (AGX), a power-plant builder riding a real demand boom, and why a steady $500 a month may be a better lens than the last spike on the chart.

Read through to the end — the framework at the close is the part most busy investors can reuse every week.

5-Year Horizon · $AGX: A late spike — then cut roughly in half from the high

"In the short run, the market is a voting machine but in the long run, it is a weighing machine."

— Benjamin Graham

A fixed $500 a month is a weighing habit: you keep adding on a schedule, instead of treating the last spike as the final score.

Argan Inc. $AGX ( ▲ 0.9% ) closed at $374.40. Five years earlier it was about $44.10. That is a +$330.30 move, or +748.98% in total — roughly 53%/yr on average if you held the whole stretch. That pace is unusual. It is not a forecast, and it is a poor default to project forward blindly.

  • Story: A long quiet base, a sharp 2026 run, then a deep giveback from the peak.

  • Math: $44.10 → $374.40 · +748.98% (~53%/yr avg)

  • If $500/mo: $30k in → roughly $245,000–$265,000 if that average multiple somehow repeated (it usually does not).

Look for on the chart: the flat stretch into 2024, the surge toward the $805.75 52-week high, and the drop to $374.40 (52-week low $240.24) — DCA would have bought more shares in the early years and fewer into the spike.

Lesson: Peak risk after a vertical run. A five-year line can stay deeply green while the recent high is already far away — here, $805.75 down to $374.40. Past results never guarantee the future, especially after a move this steep.

Next Horizon: another verified 5-year chart, same $500/month frame, same honest catch.

Want a cleaner look at this name? Open AGX on Snowball Analytics — price, fundamentals, and history in one place. Context for the chart above, not a buy signal.

Clarity over clutter — track every holding free on Snowball →

 

Today’s premium sponsor

Invest in High-Potential Startups Like These

NOTE: This is not an offer to sell, or a solicitation of an offer to purchase, any security. Example companies are provided for illustrative purposes only, are not necessarily indicative of any AV fund or investor, and are not available to future syndicate members, except potentially in the case of follow-on investments. Venture capital investing involves substantial risk, including risk of loss of all capital invested.

Alumni Ventures is giving readers early access to high-potential startup opportunities across today’s most active sectors, co-invested alongside name-brand VC firms like Andreessen Horowitz (a16z), Bessemer, & Y Combinator.

  • No cost to see deals
  • No obligation to invest
See Current AV Deals →

Argan’s Power Boom Is Real. So Is the Drop From $806.

A great five-year chart can make any stock look like an easy decision.

Argan is a good example. Five years ago, the shares traded around $44. At the $374.40 close in the 5-Year Horizon above, that is a gain of roughly 749%, even after a brutal slide from the summer peak.

A better question than “Did I miss it?” is: What is this business actually doing, what drove the run, and how would a steady investor handle a stock this volatile?

That changes the way a stock like this should be viewed.

Instead of treating the last spike as the final score, it can make more sense to look at the business, the risks, and the habit you would use to own it.

Here is how $AGX ( ▲ 0.9% ) breaks down.

What Argan Actually Does

Argan is not a household name. It is a construction and engineering company that mostly builds power plants.

Through its Gemma Power Systems and Atlantic Projects Company operations, Argan handles the engineering, procurement, and construction of natural gas-fired power plants and renewable energy facilities, plus related commissioning, maintenance, and consulting work.

It also owns The Roberts Company, an industrial construction and fabrication business, and SMC Infrastructure Solutions, which provides teledata infrastructure services.

Power is the core. In the quarter ended July 31, 2026, the Power segment brought in about $301 million of the company’s $384 million in revenue.

In plain English: when utilities and developers need a new plant built, Argan is one of the firms that can build it.

Why the Stock Ran

The story behind the run is electricity demand.

Data centers, domestic manufacturing, and the broader electrification of the economy all need more power, and a lot of that power still has to come from plants that can run on demand.

Argan’s CEO, David Watson, described the moment this way in the company’s September 9 dividend announcement: the industry is experiencing “unprecedented demand for new dispatchable power generation to support the significant load growth driven by datacenters, domestic manufacturing, and the broader electrification of the economy.”

The company is also leaning into the data-center theme directly. Its Industrial segment is building a new fabrication facility to support demand for vessels used in data centers.

When investors believe a company sits in the path of a multi-year buildout, they often pay up quickly. That is a big part of how a quiet stock turns into a vertical chart.

The Numbers Behind the Run

This was not only a story stock. The results improved sharply.

For its fiscal second quarter ended July 31, 2026, Argan reported record revenue of $384.0 million, up 61.5% from $237.7 million a year earlier.

Net income hit a record $53.3 million, or $3.76 per diluted share, compared with $2.50 a year earlier. Power segment revenue grew 53%, at a gross margin of about 22%.

The balance sheet is also strong. Argan reported about $1.03 billion in cash, cash equivalents, and investments, and no debt.

And the company ended the quarter with a project backlog of roughly $2.5 billion.

Those are real numbers from a real business. But strong numbers and a strong stock price are not the same thing, as the next section shows.

The Dividend Signal

On September 9, 2026, Argan raised its quarterly dividend 40%, from $0.50 to $0.70 per share, or $2.80 a year. The company called it the fourth consecutive annual increase.

A raise like that is usually a sign that management is confident about cash flow.

It is worth keeping in perspective, though. At a share price in the high $300s, $2.80 a year is a yield of well under 1%. Nobody owns AGX for the income today. The dividend is a signal about the business, not the main reason the stock moved.

The Honest Catch: Cut Roughly in Half

Here is the part a five-year return hides.

AGX hit a 52-week high of $805.75 on June 30, 2026. At $374.40, the stock was down more than 50% from that peak, only a few months later.

Someone who bought near the top has lost roughly half their money on paper, even though the company just reported record results.

That is not a contradiction. It is how fast-moving stocks often behave. When expectations run ahead of what the business can deliver in the near term, even good news can fail to support the price.

For Argan, investors have been watching a few things closely: the backlog slipped from about $2.9 billion at the start of the fiscal year to about $2.5 billion, some Industrial and Teledata projects performed worse than expected, and the valuation had become stretched after a powerful run.

Concentration Risk: A Few Big Projects

Argan’s business is built on a relatively small number of very large projects.

That can be great when big contracts land and ramp up at the same time. It can also make results lumpy when projects finish, start late, or slip.

The company only adds a project to backlog after it receives a notice to proceed, so the backlog number can move sharply depending on the timing of awards, starts, and completions. Argan’s own filings list the addition of new contracts, the receipt of those notices to proceed, and successful project completion as key risks.

Most of the work is also tied to power generation, and much of that to natural gas. If demand, policy, or customer preferences shift, a focused company feels it more than a diversified one.

None of that means the business is weak. It means the stock can swing hard on news about just a handful of projects.

The Bigger Idea: Steady $500 vs. Chasing the Spike

This is where the $500-a-month habit earns its place.

A fixed monthly amount buys more shares when the price is low and fewer when it is high. With AGX, $500 bought about 11 shares at $44.10, about 1.3 shares at $374.40, and only about 0.6 of a share at $805.75.

That is the quiet advantage of dollar-cost averaging. You do not need to predict the top or the bottom. The schedule automatically leans your buying toward cheaper prices.

Chasing the spike works the other way. The excitement is loudest near the peak, and that is often when people put in their biggest lump sum. In AGX’s case, that would have meant buying near $800 and watching it drop by half.

A steady plan does not remove the losses. It just keeps one bad entry from defining the whole result.

Waiting for the Perfect Entry Has a Cost Too

The opposite mistake is just as common.

After a stock gets cut in half, some investors decide to wait for the “right” moment: one more dip, one more quarter, one more clear signal.

The problem is that the perfect entry is only obvious in hindsight. Waiting can mean sitting in cash through the recovery, or never starting at all.

A monthly schedule solves both problems at once. It stops you from chasing the spike, and it stops you from freezing after the drop.

The important part is choosing an amount and a position size you can actually hold through a 50% drawdown, because this stock has already shown it can deliver one.

The Bottom Line

Argan’s business story is real: record revenue, record profit, a large backlog, a strong balance sheet, and a rising dividend, all tied to a genuine surge in power demand.

The stock’s volatility is real too. A roughly 749% five-year gain sits right next to a drop of more than half from the June high.

Both facts can be true at the same time. That is why the long run deserves more weight than the last spike.

For a stock like this, the question is not just, “Is it going up?”

It is also:

“Could I keep investing steadily, and keep holding, if it falls in half again?”

Past pace rarely continues. A 53%-a-year average over five years is unusual, and it is a poor default to project forward. This is education, not investment advice. Do your own research and consider your own situation before investing in any individual stock.

Want a simple next step for the $500 habit?

Our Fast Track Blueprint walks through a trusted online broker setup and a clear portfolio starting path.

Fast Track to Build a Winning Portfolio Blueprint
Fast Track to Build a Winning Portfolio Blueprint
Transform your investment journey with our step-by-step guide, enabling you to start investing in minutes through our trusted online broker. Discover expert insights into our smart portfolios that ...
$70.00 usd

That’s it for this episode

Thanks for reading. This format is built to be fast to open, clear to understand, and useful enough to act on — without pretending past returns continue forever.

Disclaimer: This newsletter is for informational purposes only and is not financial advice. Consult a qualified advisor before investing.